Thrive Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
3,372
+355
| +12% | +$144K | 0.22% | 53 |
|
|
2025
Q1 | $1.5M | Buy |
3,017
+54
| +2% | +$26.9K | 0.29% | 40 |
|
|
2024
Q4 | $1.54M | Sell |
2,963
-247
| -8% | -$129K | 0.28% | 42 |
|
|
2024
Q3 | $1.99M | Buy |
3,210
+44
| +1% | +$27.2K | 0.36% | 34 |
|
|
2024
Q2 | $1.75M | Buy |
3,166
+47
| +2% | +$26K | 0.34% | 34 |
|
|
2024
Q1 | $1.81M | Buy |
3,119
+339
| +12% | +$197K | 0.37% | 33 |
|
|
2023
Q4 | $1.48M | Sell |
2,780
-141
| -5% | -$74.9K | 0.33% | 37 |
|
|
2023
Q3 | $1.48M | Buy |
2,921
+144
| +5% | +$72.9K | 0.39% | 32 |
|
|
2023
Q2 | $1.45M | Sell |
2,777
-236
| -8% | -$123K | 0.38% | 30 |
|
|
2023
Q1 | $1.74M | Buy |
3,013
+422
| +16% | +$243K | 0.45% | 27 |
|
|
2022
Q4 | $1.43M | Buy |
2,591
+111
| +4% | +$61.1K | 0.41% | 31 |
|
|
2022
Q3 | $1.26M | Buy |
2,480
+372
| +18% | +$189K | 0.44% | 32 |
|
|
2022
Q2 | $1.15M | Buy |
2,108
+396
| +23% | +$215K | 0.4% | 34 |
|
|
2022
Q1 | $1.01M | Buy |
1,712
+180
| +12% | +$106K | 0.3% | 40 |
|
|
2021
Q4 | $1.02M | Buy |
+1,532
| New | +$1.02M | 0.35% | 33 |
|